Early Lapatinib-Induced Skin Rash Predicts Better Survival With

Early Lapatinib-Induced Skin Rash Predicts Better Survival With

4.7
(637)
Write Review
More
$ 12.00
Add to Cart
In stock
Description

Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.

Lapatinib as first-line treatment for muscle-invasive urothelial

Molecules, Free Full-Text

Lapatinib: Package Insert

Wendy A. Woodward, M.D., Ph.D., Radiation Oncologist

Page 1537 – Cancer Therapy Advisor

First-line lapatinib trials in metastatic breast cancer

Lapatinib: Package Insert

PDF] Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO

Pyrotinib-based therapeutic approaches for HER2-positive breast